| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 10/27/2011 | US20110262405 Apparatus, system, and method for harvesting improved bone graft material with reamer-irrigator-aspirator (ria) device |
| 10/26/2011 | EP2380587A1 Use of C1 inhibitor for the prevention of ischemia-reperfusion injury |
| 10/26/2011 | EP2380586A2 Oligopeptides as coating material for medical products |
| 10/26/2011 | EP1259481B1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same |
| 10/26/2011 | CN101433712B Liver perfusate and preparation method thereof |
| 10/25/2011 | US8044182 Adiponectin and uses thereof |
| 10/25/2011 | US8043628 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides |
| 10/20/2011 | WO2011128424A1 Methods and compositions for improving implant osseointegration |
| 10/20/2011 | CA2795886A1 Methods and compositions for improving implant osseointegration |
| 10/19/2011 | EP2376073A2 Dermal application of vasoconstrictors |
| 10/18/2011 | CA2466499C Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 10/12/2011 | CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 10/06/2011 | WO2011123061A1 Amphiphilic linear peptide/peptoid and hydrogel comprising the same |
| 10/06/2011 | WO2011121354A1 The therapeutic use of tetrathiomolybdate |
| 10/05/2011 | EP2371371A2 Composition for preventing adhesion |
| 10/05/2011 | CN1817883B New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 09/29/2011 | US20110236405 Coagulation factor modulation for controlling transplant organ size |
| 09/28/2011 | EP2367564A1 Norrin in the treatment of diseases associated with an increased tgf-beta activity |
| 09/28/2011 | EP1463531B1 Methods for inhibiting ocular processes |
| 09/27/2011 | US8026346 Tribonectins |
| 09/27/2011 | US8025883 Antagonists and methods for inhibiting angiogenesis |
| 09/22/2011 | US20110229452 Ophthalmic Surgical Irrigating Solutions Containing Hyaluronidase |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/20/2011 | CA2223573C Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device |
| 09/19/2011 | DE202010009243U1 Zubereitung Preparation |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224215 Pre-surgical treatment |
| 09/14/2011 | EP1713480B1 The use of quaternary pyridinium salts as vasoprotective agents |
| 09/14/2011 | CN102178691A Starch stypticum and preparation method thereof |
| 09/09/2011 | WO2011109387A1 Radiotherapy combined with hypoxic cell sensitizers |
| 09/08/2011 | US20110217352 Development of a human colloidal bone graft material |
| 09/08/2011 | US20110217313 Treatment of orthopedic conditions |
| 09/08/2011 | DE102010010430A1 Filler material, useful for filling an ophthalmic implant, preferably self-accommodative lenses, comprises free-flowing silicone oils having a predetermined refractive index |
| 09/07/2011 | CN102177178A Anti-IL-12/IL-23 antibodies |
| 09/07/2011 | CN101766650B Washing liquor for operation and method for preparing same |
| 09/01/2011 | US20110213470 Methods for using a three-dimensional stromal tissue to promote angiogenesis |
| 08/25/2011 | US20110207913 Induction of Gene Expression Using a High Concentration Sugar Mixture |
| 08/24/2011 | EP2360254A1 Assays for screening anti-pd-1 antibodies and uses thereof |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/16/2011 | CA2493423C Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury |
| 08/09/2011 | CA2474645C Compositions and methods for systemic inhibition of cartilage degradation |
| 08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 08/03/2011 | CN102138979A Pharmaceutical composition for preventing and treating intestinal adhesion after abdominal operation |
| 07/28/2011 | US20110183010 Cardioplegic preparation |
| 07/28/2011 | US20110182957 Cellulosics for tissue replacement |
| 07/28/2011 | DE102010001179A1 Verwendung von Hydrogelen auf Basis guluronsäure- und/oder mannuronsäurehaltiger Polysaccharide zur Behandlung von Beschädigungen des Nervensystems, zur Förderung des Nervenwachstums, zur Behandlung von neurodegenerativen Erkrankungen und zur Kultivierung von Neuronen Guluronsäure- use of hydrogels based and / or mannuronsäurehaltiger polysaccharides for treatment of damage to the nervous system, for the promotion of nerve growth, for the treatment of neurodegenerative diseases and for the cultivation of neurons |
| 07/27/2011 | EP1744746B1 Use of melatonin in preventing postoperative complications |
| 07/26/2011 | CA2427655C Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization |
| 07/26/2011 | CA2367787C Ligands for metabotropic glutamate receptors |
| 07/21/2011 | US20110177595 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof |
| 07/20/2011 | CN1917896B Surface protection of exposed biological tissues |
| 07/20/2011 | CN102127023A 7-membered ring compound, process for producing the same, and use thereof |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/14/2011 | US20110171215 Pd-1 specific antibodies and uses thereof |
| 07/13/2011 | EP1965831B1 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 07/12/2011 | CA2483097C Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 07/07/2011 | US20110166174 Compounds modulating c-kit and c-fms activity and uses therefor |
| 07/07/2011 | US20110166089 Solution for tissue adhesion prevention and method for tissue adhesion prevention |
| 07/07/2011 | US20110165244 Bioresponsive polymer formulations for delivery of bioactive agents |
| 07/07/2011 | US20110165096 Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same |
| 07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
| 07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
| 07/06/2011 | CN101669964B Surgery anti-adhesion agent and preparation method thereof |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 06/30/2011 | US20110159000 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions |
| 06/29/2011 | EP2338886A2 Naphthalene derivatives |
| 06/29/2011 | CN102107024A Anti-adhesion spraying |
| 06/23/2011 | US20110151011 Decellularized Adipose Tissue |
| 06/16/2011 | US20110144182 Treatment of surgical adhesions |
| 06/16/2011 | US20110144113 Triazolotriazines as kinase inhibitors |
| 06/14/2011 | US7960405 Prodrug of Rapamycin analog; chemokine receptor antagonist; antiproliferative, antiinflammatory , anticarcinogenic agent, anticoagulant; autoimmune diseases; restenosis; stents, catheters, by-pass graft; drug delivery; balloon overcoated with drugs |
| 06/08/2011 | CN102088977A Cardioplegia solution for cardiac surgery |
| 06/08/2011 | CN101156969B Anti-conglutination material containing calcium ion and carboxymethyl cellulose after operation as well as its preparing method |
| 06/08/2011 | CN101128578B Method of inducing differentiation of skeletal muscle cell |
| 06/07/2011 | CA2423190C Angiogenic agents and their uses |
| 06/02/2011 | US20110130353 Highly purified antiendotoxin compound |
| 06/01/2011 | EP2327705A1 Podophyllotoxins as antiproliferative agents |
| 06/01/2011 | EP2327416A1 Pharmacological vitreolysis using truncated plasmin |
| 06/01/2011 | EP2327415A1 Pharmacological vitreolysis using truncated plasmin |
| 06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
| 05/25/2011 | EP2325205A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 05/25/2011 | EP2324851A1 Methods of administering anti-TNFalpha antibodies |
| 05/25/2011 | EP2324829A1 Therapeutic inhibitors of vascular smooth muscle cells |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | CN101056662B Adhesion preventive material and method of preventing adhesion |
| 05/24/2011 | CA2384378C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 05/19/2011 | US20110117048 Method and composition for use in preparation of a patient for surgery |
| 05/18/2011 | EP2320936A1 Prevention and treatment of radiation injury |
| 05/12/2011 | WO2011055047A1 Aqueous composition comprising gold nanoparticles, serum albumin and/or collagen for laser tissue welding |
| 05/12/2011 | CA2780274A1 Fragmented hydrogels |
| 05/11/2011 | CN102048715A New effect and applications of trans-acomhole |
| 05/10/2011 | CA2485535C Modified release pharmaceutical formulation |
| 05/04/2011 | EP2316451A1 Use of melatonin in preventing postoperative complications |
| 04/28/2011 | US20110097367 Monolithic in-situ cross-linked alginate implants |
| 04/27/2011 | CN102028706A Flushing liquid for liver-cancer surgical incisions |
| 04/26/2011 | CA2415397C Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 04/21/2011 | WO2010063030A3 Dermal application of vasoconstrictors |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311432A1 Prevention and reduction of blood loss |
| 04/20/2011 | CN102018868A Allium macrostemon preparation for preventing intestinal adhesions and preparation method thereof |